F32.0
Conditions
Interventions
Group 1: hypnotherapy, duration 6 weeks
Group 2: progressive muscle relaxation, duration 6 weeks
Group 3: waiting list
Sponsors
Charité - Universitätsmedizin Berlin Institut für Sozialmedizin, Epidemiologie und Gesundheitsokönomie
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: -Women, men, and individuals of diverse genders between the ages of 18 and 70. -Subjective stress level in the past week on the Visual Analog Scale (VAS) 40 mm (VAS 0 - 100 mm, 0 = no stress and 100 = maximum imaginable stress). -Diagnosis of mild depression according to ICD-10 (F32.0, F33.0) by a specialist in psychiatry and psychotherapy or a licensed psychological psychotherapist. -Duration of depressive symptoms for at least 2 weeks. -Capacity to provide informed consent and signed informed consent form. -Technical equipment to participate in online courses and complete online questionnaires.
Exclusion criteria
Exclusion criteria: -Known history of severe trauma resulting in post-traumatic stress disorder. -Diagnosed personality disorder. -Current or past psychotic disorder -Acute self-harm or suicidality -Known severe obsessive-compulsive disorder. -Alcohol and drug dependency. -Presence of moderate or severe acute or chronic physical illness. -Participation in another study on depression within the last 2 months prior to study enrollment. -Lack of understanding of the German language. -Ongoing disability retirement process. -Use of hypnosis, self-hypnosis, autogenic training, or progressive muscle relaxation (PMR) currently or within the last 2 months. -Diagnosis of moderate and severe depressive episode according to ICD-10 (F32.1, F32.2, F33.1, F33.2) by a specialist in psychiatry and psychotherapy or a licensed psychological psychotherapist.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| At baseline and after 6 weeks: -Subjective stress level on the visual analogue scale (VAS 0 – 100 mm) -Perceived stress level based on the Perceived Stress Scale (PSS) -Severity of the depressive symptoms based on the Beck's Depression Inventory -II (BDI-II) -Depression based on the Allgemeine Depressionsskala (ADS-K) -Self-efficacy (SWE) questionnaire -Health-related quality of life based on the European Quality of Life 5 Dimensions 5 Level Version (EQ-5D-5L) -The overall assessment of the changes based on the Patient Global Impression of Change (PGIC) furthermore: -Subjective stress level on the visual analogue scale (VAS 0 – 100 mm) after week three -Suggestibility and hypnotic susceptibility based on the Harvard Group Scale of Hypnotic Susceptibility, 5-Item Short-Version (HGSHS-5:G) at baseline -Suggestibility and hypnotic susceptibility based on the Creative Imagination Scale (CIS) at baseline -Frequency of their hypnosis or PMR practice by themselves with the audio records between baseline and week 6 -Beginning or changes of a psychotherapy or psychotherapy trial sessions between baseline and week 6 -Start or change of antidepressant psychopharmacotherapy between baseline and week 6 -Presence of pre-, peri-, or postmenopausal depression at baseline -Adverse events and serious adverse events tbetween baseline and week 6 -Assessment of the study treatment at baseline and week 6 -Assessment of complaints since the beginning of the study will be assessed in week 6 -Limitations in carrying out usual everyday work due to stress symptoms or depressive symptoms at baseline and week 6 -Number of sick leave days due to depressive symptoms at baseline and week 6 - qualitative outcome parameter: eight study participants from each of the two intervention groups will be asked about the feasibility and subjective change, expectations, safety, quality of life and experiences of the telemedical intervention in a semi-standardized interview after the end of the study inter | — |
Secondary
| Measure | Time frame |
|---|---|
| this is an exploratory study without differentiation into a primary and secondary outcome | — |
Countries
Germany
Contacts
Public ContactJulia Siewert
Charité - Universitätsmedizin Berlin Institut für Sozialmedizin, Epidemiologie und Gesundheitsokönomie
Outcome results
None listed